Literature DB >> 17553889

Reversible inhibition of the fusion activity of measles virus F protein by an engineered intersubunit disulfide bridge.

Jin K Lee1, Andrew Prussia, James P Snyder, Richard K Plemper.   

Abstract

In search of target sites for the development of paramyxovirus inhibitors, we have engineered disulfide bridges to introduce covalent links into the prefusion F protein trimer of measles virus. F-Edm-452C/460C, predicted to bridge head and stalk domains of different F monomers, shows a high degree of proteolytic maturation and surface expression, predominantly as stable, dithiothreitol-sensitive trimers, but no fusion activity. Reduction of disulfide bridges partially restores activity. These findings underscore the importance of reversible intersubunit interactions between the stalk and head domains for F activity. Noncovalent small molecules mimicking this behavior may constitute a potent strategy for preventing paramyxovirus entry.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17553889      PMCID: PMC1951371          DOI: 10.1128/JVI.00754-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  The penultimate rotamer library.

Authors:  S C Lovell; J M Word; J S Richardson; D C Richardson
Journal:  Proteins       Date:  2000-08-15

Review 2.  Virus membrane fusion proteins: biological machines that undergo a metamorphosis.

Authors:  R E Dutch; T S Jardetzky; R A Lamb
Journal:  Biosci Rep       Date:  2000-12       Impact factor: 3.840

Review 3.  Mechanisms of viral membrane fusion and its inhibition.

Authors:  D M Eckert; P S Kim
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

4.  Mutations in the putative HR-C region of the measles virus F2 glycoprotein modulate syncytium formation.

Authors:  Richard K Plemper; Richard W Compans
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

5.  Multiple sequence alignment with the Clustal series of programs.

Authors:  Ramu Chenna; Hideaki Sugawara; Tadashi Koike; Rodrigo Lopez; Toby J Gibson; Desmond G Higgins; Julie D Thompson
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

Review 6.  HIV fusion and its inhibition in antiretroviral therapy.

Authors:  Michael Greenberg; Nick Cammack; Miklos Salgo; Lynn Smiley
Journal:  Rev Med Virol       Date:  2004 Sep-Oct       Impact factor: 6.989

Review 7.  HIV-1 entry and entry inhibitors as therapeutic agents.

Authors:  Linda D Starr-Spires; Ronald G Collman
Journal:  Clin Lab Med       Date:  2002-09       Impact factor: 1.935

8.  Measles virus envelope glycoproteins hetero-oligomerize in the endoplasmic reticulum.

Authors:  R K Plemper; A L Hammond; R Cattaneo
Journal:  J Biol Chem       Date:  2001-09-04       Impact factor: 5.157

9.  Strength of envelope protein interaction modulates cytopathicity of measles virus.

Authors:  Richard K Plemper; Anthea L Hammond; Denis Gerlier; Adele K Fielding; Roberto Cattaneo
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

10.  A dual-functional paramyxovirus F protein regulatory switch segment: activation and membrane fusion.

Authors:  Charles J Russell; Karen L Kantor; Theodore S Jardetzky; Robert A Lamb
Journal:  J Cell Biol       Date:  2003-10-27       Impact factor: 10.539

View more
  27 in total

1.  A designed redox-controlled caspase.

Authors:  Witold A Witkowski; Jeanne A Hardy
Journal:  Protein Sci       Date:  2011-08       Impact factor: 6.725

2.  Transmembrane Domain Dissociation Is Required for Hendra Virus F Protein Fusogenic Activity.

Authors:  Kerri Beth Slaughter; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

3.  Mechanism for active membrane fusion triggering by morbillivirus attachment protein.

Authors:  Nadine Ader; Melinda Brindley; Mislay Avila; Claes Örvell; Branka Horvat; Georg Hiltensperger; Jürgen Schneider-Schaulies; Marc Vandevelde; Andreas Zurbriggen; Richard K Plemper; Philippe Plattet
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

4.  Reversible inhibition of fusion activity of a paramyxovirus fusion protein by an engineered disulfide bond in the membrane-proximal external region.

Authors:  Aarohi Zokarkar; Sarah A Connolly; Theodore S Jardetzky; Robert A Lamb
Journal:  J Virol       Date:  2012-09-05       Impact factor: 5.103

5.  Structure of the Newcastle disease virus F protein in the post-fusion conformation.

Authors:  Kurt Swanson; Xiaolin Wen; George P Leser; Reay G Paterson; Robert A Lamb; Theodore S Jardetzky
Journal:  Virology       Date:  2010-05-02       Impact factor: 3.616

6.  Efficient replication of a paramyxovirus independent of full zippering of the fusion protein six-helix bundle domain.

Authors:  Melinda A Brindley; Philippe Plattet; Richard Karl Plemper
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

7.  Design and Structure of an Engineered Disulfide-Stabilized Influenza Virus Hemagglutinin Trimer.

Authors:  Peter S Lee; Xueyong Zhu; Wenli Yu; Ian A Wilson
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

8.  Structures of the prefusion form of measles virus fusion protein in complex with inhibitors.

Authors:  Takao Hashiguchi; Yoshinari Fukuda; Rei Matsuoka; Daisuke Kuroda; Marie Kubota; Yuta Shirogane; Shumpei Watanabe; Kouhei Tsumoto; Daisuke Kohda; Richard Karl Plemper; Yusuke Yanagi
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-20       Impact factor: 11.205

Review 9.  Measles Resurgence and Drug Development.

Authors:  Richard K Plemper
Journal:  Curr Opin Virol       Date:  2020-04-01       Impact factor: 7.090

10.  Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors.

Authors:  Dan Yan; Sujin Lee; Vidhi D Thakkar; Ming Luo; Martin L Moore; Richard Karl Plemper
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.